Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model

Table 1 Cell growth inhibition of HepG2 cells by 24 h treatment with 0.1–0.3% DMSO, RES or 5-FU

Cell growth inhibition ratio (%)
Cell groups		Res (μM)							5-FU (μM)
	DMSO	10	20	30	50	100	200	300	100
HepG2	0.046	11.88	17.49	22.03	30.50	45.95	51.45	65.93	50.86
CAV1	0.035	19.72	24.08*	37.13*	45.54*	57.54*	68.32*	87.89*	64.66*
CAVM1	15.97	22.63	25.03	33.82	45.98	55.78	72.34	48.48	0.047
CAVM2	13.91	19.39	26.44	34.77	47.55	57.27	76.56	42.46	0.029
RNAi	0.023	8.15	12.94	16.07*	24.34*	33.52*	41.23*	55.37*	32.83*
GFP	0.034	10.32	18.07	22.34	30.84	45.37	54.04	67.12	53.23
CAV1	0.035	19.72	24.08*	37.13*	45.54*	57.54*	68.32*	87.89*	64.66*

ISSN: 1479-5876